首页> 外国专利> VACCINE COMPOSITION COMPRISING MTBK_20640 PROTEIN FOR PREVENTING TUBERCULOSIS

VACCINE COMPOSITION COMPRISING MTBK_20640 PROTEIN FOR PREVENTING TUBERCULOSIS

机译:包含MTBK_20640蛋白质的疫苗组合物,用于预防结核病

摘要

The present invention relates to a vaccine composition comprising an MTBK_20640 protein for preventing tuberculosis, and to a pharmaceutical composition comprising MTBK_20640 protein for treating or preventing tuberculosis. According to the present invention, the MTBK_20640 protein exhibits high capacity of generating IFN-γ in the spleen and lung of an animal model induced to have infection by tubercular bacillus, and retains rapid formation of acquired protective immunity and memorization of T-cells, thereby effectively preventing tuberculosis. Particularly, the MTBK_20640 protein induces generation of multifunctional T-cells recently known to be crucial in preventing tuberculosis. Also, the MTBK_20640 protein can be used to treat tuberculosis, and is useful to prevent recurrence or reinfection of highly pathogenic tuberculosis having a high recurrence rate and to increase treatment efficacy.;COPYRIGHT KIPO 2017
机译:本发明涉及包含用于预防结核病的MTBK_20640蛋白的疫苗组合物,以及涉及用于治疗或预防结核病的包含MTBK_20640蛋白的药物组合物。根据本发明,MTBK_20640蛋白表现出产生IFN-γ的高能力。在被结核杆菌诱导感染的动物模型的脾脏和肺中,它能迅速形成获得的保护性免疫力并记忆T细胞,从而有效地预防了结核病。特别是,MTBK_20640蛋白可诱导多功能T细胞的产生,最近已知这种多功能T细胞对于预防结核病至关重要。此外,MTBK_20640蛋白可用于治疗结核病,可用于预防复发率高的高致病性结核病的复发或再感染并提高治疗效果。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号